Publications

Search our bibliography using the filters on the right-hand side.

Displaying 401 through 436 of 436 publications.

Njue AI, Prichard RK. Efficacy of ivermectin in calves against a resistant Cooperia oncophora field isolate. Parasitol Res. 2004 Aug 1;93(5):419-22.

Vanderpuije A, Hallfors D, Halpern C, Iritani B, Waller M. Revealing more factors in the hiv/sti risk among African American adolescents. Poster presented at the Annual Meeting of the Society for Prevention Research; May 2004.

Midkiff KD. General interviewing techniques for the HPV vaccine trial computer assisted personal interview (CAPI). Poster presented at the Guanacaste Epidemiology Project; May 2004.

Rothman KJ, Mahon BE. Confounding and effect-measure modification in the evaluation of immunogenic agents. Eur J Epidemiol. 2004 Mar;19(3):205-7.

Vanderpuije A, Hallfors D, Halpern C, Iritani B, Waller M. Another piece of the puzzle: revealing more factors in the hiv/sti risk among African American adolescents. Poster presented at the Annual National STD Prevention Conference; March 2004.

Mast TC, DeMuro-Mercon CJ, Granger AL, Santanello N, Huyett J, Goldstone S. The psychosocial impact of human papilloma virus (HPV) and related interventions among heterosexual men (HSM) and men who have sex with men (MSM). Poster presented at the 21st International Papillomavirus Conference; February 2004.

Bahl R, Sinha A, Poulos C, Whittington D, Sazawal S, Kumar R, Mahalanabis D, Acosta CJ, Clemens JD, Bhan MK. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy. J Health Popul Nutr. 2004 Jan 1;22(3):304-10.

Enger C, Nordstrom BL, Thakrar B, Sacks S, Rothman KJ. Health outcomes among patients receiving oseltamivir. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(4):227-37.

DeMuro-Mercon CJ, Goldstone SE, Huyett JW, Santanello N, Mast TC. Developing a new measure to assess the psychosocial impact and burden of hpv illness on men who have sex with men (MSM). Poster presented at the Papillomavirus 21st International Conference and Clinical Workshop; 2004.

Pearson IV, Page MD, van Spanning RJM, Ferguson SJ. A mutant of paracoccus denitrificans with disrupted genes coding for cytochrome c550 and pseudoazurin establishes these two proteins as the in vivo electron donors to cytochrome cd1 nitrite reductase. J Bacteriol. 2003 Nov 1;185(21):6308-15.

Iritani B, Hallfors D, Halpern CT, Hussey JM, Bauer D, Guo G, Cho H, Vanderpuije A. Racial/ethnic differences in sti/hiv risk: sex and substance use patterns among adolescents. Poster presented at the Annual Meeting of the American Public Health Association; November 2003.

Hicks KA, Honeycutt AA, Scotton C. A model for allocating HIV prevention resources in local jurisdictions. Poster presented at the Prevention Effectiveness and Health Economics Seminar at CDC; November 2003.

Hallfors D, Halpern C, Bauer DJ, Guo G, Hussey JM, Cho H, Iritani B, Waller MW, Kaestle A, Vanderpuije A. Hiv in young adulthood: pathways and prevention. Presented at the Binational Workshop on Drug Abuse and Addiction; October 2003.

Liu Z, Eaton SC, McQuay LJ, Mines D, Irish WD, Wang L. Protective value of influenza vaccination for other household members of vaccinated children. Poster presented at the 2003 41st Annual Meeting of the Infectious Disease Society of America; October 2003. San Diego, CA.

Earnshaw SR, Wirth K, Hicks KA. Pilot test of the RTI HIV prevention resource allocation tool. Presented at the Florida Department of Health; August 2003.

Hicks KA, Honeycutt AA, Earnshaw SR, Richter A. A tool for comparing allocations of HIV prevention resources. Presented at the National HIV Prevention Conference; August 2003.

Poulos C, Cahn D, Whittington D, Thoa L, Utomo N, Hoa N. Household demand for typhoid fever vaccines in Hue City, Vietnam: implications for immunization programs. Poster presented at the 4th World Congress of the International Health Economics Association; June 2003.

Hallfors D, Halpern CT, Bauer DJ, Iritani B, Waller MW, Hussey JM, Cho H, Guo G, Vanderpuije A. Examining sex and drug patterns for hiv prevention. Poster presented at the Annual Meeting of the Society for Prevention Research; June 2003.

Earnshaw SR, Richter A, Hicks KA, Honeycutt A. The allocation of HIV prevention funds. Poster presented at the 2003 ISPOR 8th Annual International Meeting; May 2003.

Hicks KA, Honeycutt A, Earnshaw SR, Richter A. Models for the efficient allocation of HIV prevention resources. Presented at the Community Planning Leadership Summit for HIV Prevention; March 2003.

Earnshaw SR, Richter A, Hicks K, Honeycutt A. The allocation of HIV prevention funds. Value Health. 2003 Jan 1;6(3):254.

Honeycutt AA, Richter A, Earnshaw SR, Hicks KA. A model for allocating HIV prevention resources. Poster presented at the CDC's "Practical Use of CEA" 01158 Grantee Meeting; December 2002.

Meads DM, Whalley D, Van t' Kooster GA. Review of QoL and HRQoL instruments available for measuring outcome in HIV/AIDS. Poster presented at the 2002 ISPOR 5th Annual European Congress; November 2002. Rotterdam, The Netherlands. [abstract] Value Health. 2002 Nov 3; 5(6):572.

Overland GB, Vatten L, Rhodes T, DeMuro C, Jacobsen G, Vada K, Angelsen A, Girman CJ. Lower urinary tract symptoms, prostate volume and uroflow in Norwegian community men. Eur Urol. 2001 Jan 1;39(1):36-41.

Estrada CA, Unterborn JN, Price J, Thompson D, Gibson L. Judging the effectiveness of clinical pathways for pneumonia: the role of risk adjustment. Eff Clin Pract. 2000 Sep 1;3(5):221-8.

Mauskopf JA, Cates SC, Griffin AD, Neighbors DM, Lamb SC, Rutherford C. Cost-effectiveness of zanamivir for the treatment of influenza in a high-risk population in Australia. Pharmacoeconomics. 2000 Jun;17(6):611-20. doi: 10.2165/00019053-200017060-00007.

Garcia Rodriguez LA, Duque A, Castellsague J, Perez-Gutthann S, Stricker BH. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol. 1999 Dec 1;48(6):847-52.

Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13404-8.

Yates ME, Stellato RK, Johannes CB, Avis NE. The importance of AIDS-related knowledge for mid-life and older women. AIDS Educ Prev. 1999 Jun;11(3):224-31.

White (Gilsenan) AE, Morris CB. Influenza vaccination and treatment policies in sixty North Carolina nursing homes. Poster presented at the American Pharmaceutical Association National Meeting; 1997. Los Angeles, CA.

Rothman KJ, Lanza L, Lal A, Peskin EG, Dreyer NA. Incidence of pelvic inflammatory disease among women treated for gonorrhea and chlamydia. Pharmacoepidemiol Drug Saf. 1996 Nov 5;5(6):409-14.

Arribas F, Pradas F, Arana A, Mareca R, Moliner J, Gomez L. Incidence of pulmonary tuberculosis in a reference hospital. Comparison of three sources of information. Presented at XII Reunión Científica de la Sociedad Española de Epidemiología; 1994. Alicante, Spain.

Cuadrado ML, Astier P, Mareca R, Arana A, Lopez LI. Accidental exposure to HIV among staff members of HCU-Z. Presented at I Congreso Iberoamericano de Epidemiología; 1992. Granada, Spain.

Lanes SF, Rothman KJ. Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome. J Clin Epidemiol. 1990 Jan 1;43(12):1379-85.

Rothman KJ. Zaire: nonsexual household transmission of AIDS. JAMA. 1986 Dec 12;256(22):3091-2.

Rothman KJ. Preventive and community medicine. In: Clark DW, MacMahon B, editors. Diseases of the mouth. 2nd ed. Boston: MA. Little, Brown and Co; 1981.